About this trial
One of the most common infant developmental diseases is Hip dysplasia which is mostly seen among female' babies and leads to hip instability due to partial or full hip dislocation \[1\]. Physical therapy's role plays a significant role in treating hip dysplasia by creating new walking habits as an adaptation way and compensation for the deformity \[3\]. Focusing on the muscles that produce hip abduction force is a basic item of the hip dysplasia rehabilitation program \[4\]. Cross-legged sitting position can be considered as a common and easy position that might enhance the range of motion of the lower limb joints \[5\].
While unilateral hip developmental dysplasia has been widely distributed among newborns, especially in the last few years, the role of engaging the cross-legged sitting technique as a part of physical therapy and rehabilitation programs on improving the temporospatial parameters, muscular electrical activity and foot pressure distributing is still not clear. Therefore, this study aimed to analyze the effects of engaging the cross-legged sitting technique as a part of physical therapy and rehabilitation program among patients with UHDD by comparing the group who participated in rehabilitation program with CLS to the other without.
To understand the importance of including Cross-legged sitting technique in physical therapy and rehabilitation program of Unilateral Hip Developmental Dysplasia (UHDD) to enhance the spatial and temporal measures, achieving a healthy distribution of foot pressure, increasing the electrical activity of lower limb muscles and improving the overall gait pattern.
No risks at all. All instruments and techniques in this study are safe and used regularly without any hazards.
The data will be stored and archived on a password-protected computer for safety and security purposes. After accomplishing the research and getting the outcomes, the results of the research may be published as an academic article in a peer-reviewed journal. In another word, no personal data will be published at all.
Taking part in the study and withdrawing at any time is completely voluntary with no need to give any reason.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
age group from 9 months to 10 years old
all participants suffer from Unilateral Hip Developmental Dysplasia (UHDD)
participants should be healthy in general
Disqualifiers
None
Trial design
Parallel
Treatments tested in this trial
Cross- legged sitting position
Other interventionCLS in which the legs were crossed with hip and knee joints flexed
Physical Therapy Rehabilitation Program
Other interventionStrengthening Exercises Stretching Exercises Range of Motion Exercises
Treatment groups
Trial outcomes
Primary outcomes
Gait Temporospatial Parameters
Cadence will be measured by Gait Rite
Muscle Electrical Activity
Muscle Electrical Activity will be measured by Electromygraphy
Secondary outcomes
Foot Pressure
Average pressure will be measured using the foot pressure system
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: